******BHVN is still on the watchlist of many investors as a possible takeover target but the options market today seen some major bearish bets placed, someone knows something we don't know.*******
AVERAGE ANALYSTS PRICE TARGET $76 AVERAGE ANALYSTS RECOMMENDATION BUY
COMPANY PROFILE Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT